Biogen Inc (NASDAQ:BIIB)

Delayed Data
As of Apr 24
 -28.57 / -6.64%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 20 analysts offering 12-month price forecasts for Biogen have a median target of 499.00, with a high estimate of 554.00 and a low estimate of 350.00. The median estimate represents a +24.22% increase from the last price of 401.71.

Analyst Recommendations

The current consensus among 25 polled investment analysts is to Buy stock in Biogen. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Apr 24

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -4.69%
Growthannually 22.59%


Growthquarterly 0.18%
Growthannually 15.41%
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account